Potential treatment for glioblastoma multiforme
Potential treatment for glioblastoma multiforme TVI-Brain-1 immunotherapy, a potential treatment for glioblastoma multiforme, developed by TVAX Biomedical, has received Fast track designation by the U.S. Food and Drug Administration. Fast track is given to an experimental treatment for a disease that does not yet have one, or to a treatment that offers better results than […]
New discovery on Covid-19
The viral protein of SARS-COV-2 called SPIKE links through its binding domain to the ACE2 receptor located on many human cells. This allows the virus to enter the cells. Researchers then performed mutations on the SPIKE binding domain and most of them alter the expression of the binding domain and its binding to ACE2. This study therefore identified regions on the surface of the […]